Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Ropivacaine × Clear all

Phase

Status

Completed 11 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 1 Lung Neoplasms 1 ENT Cancers 1 Breast Neoplasms 1

Interventions

Capecitabine 16 Trastuzumab 13 pertuzumab 12 Letrozole 11 Docetaxel 11 Cyclophosphamide 11 pyrotinib 9 Paclitaxel 9 Carboplatin 9 sacituzumab govitecan 7 palbociclib 7 abemaciclib 7 Fulvestrant 7 trastuzumab deruxtecan 6 Tamoxifen 6 Radiotherapy 6 Epirubicin 6 Drug Therapy 6 Anastrozole 6 eribulin 5 dalpiciclib 5 Vinorelbine 5 Standard of Care 5 Neoadjuvant Therapy 5 exemestane 4 Sentinel Lymph Node Biopsy 4 Gemcitabine 4 Doxorubicin 4 ribociclib 3 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07079436 2025-07-23

EIT

Fudan University

Phase NA Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡